Indication

Psoriasis

Psoriasis is a chronic, immune-mediated inflammatory disorder primarily affecting the integumentary system, though it can involve extracutaneous tissues such as the joints. Read more about Psoriasis

375 drugs 194 manufacturers

Advertisement

Drugs that treat it

Common Psoriasis therapies.

Showing 325–333 of 375 drugs

DEXAMETHASONE

GLUCOCORTICOSTEROIDS·DISSEMINATED TUBERCULOSIS·+61
Hikma Pharmaceuticals USA

DEXAMETHASONE

GLUCOCORTICOSTEROIDS·DISSEMINATED TUBERCULOSIS·+61
NOVITIUM/ANI PH

PREDNISONE

GLUCOCORTICOSTEROIDS·PULMONARY TUBERCULOSIS·+67
NOVITIUM/ANI PH

DEXAMETHASONE

GLUCOCORTICOSTEROIDS·DISSEMINATED TUBERCULOSIS·+61
Hikma Pharmaceuticals USA
Filter & compare in the drug finder →Opens the drug finder with Psoriasis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Psoriasis.

Psoriasis is a chronic, immune-mediated inflammatory disorder primarily affecting the integumentary system, though it can involve extracutaneous tissues such as the joints.

Pathophysiologically driven by dysregulated innate and adaptive immune signaling—predominantly along the interleukin-23 and interleukin-17 pathways—it leads to marked keratinocyte hyperproliferation, abnormal epidermal differentiation, and local neoangiogenesis.

Clinically, it most frequently manifests as sharply demarcated, erythematous plaques covered by silvery-white scales that favor extensor surfaces, the scalp, and the lumbosacral region, although clinical variants include guttate, pustular, inverse, and erythrodermic presentations.

While it can present across any age group, it is frequently associated with systemic inflammatory comorbidities, including psoriatic arthritis, cardiometabolic disease, and psychological distress.

Personalize your experience

Follow Psoriasis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it